Pre Tax Income - Intercept Pharmaceuticals Inc (F:I4P) - Alpha Spread
I

Intercept Pharmaceuticals Inc
F:I4P

Watchlist Manager
Intercept Pharmaceuticals Inc
F:I4P
Watchlist
Price: 17.52 EUR Market Closed
Market Cap: 732.8m EUR
Have any thoughts about
Intercept Pharmaceuticals Inc?
Write Note

Intercept Pharmaceuticals Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Intercept Pharmaceuticals Inc
Pre-Tax Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
I
Intercept Pharmaceuticals Inc
F:I4P
Pre-Tax Income
-$57.5m
CAGR 3-Years
44%
CAGR 5-Years
30%
CAGR 10-Years
4%
Abbvie Inc
NYSE:ABBV
Pre-Tax Income
$7.1B
CAGR 3-Years
5%
CAGR 5-Years
14%
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Pre-Tax Income
$1.5B
CAGR 3-Years
-39%
CAGR 5-Years
-29%
CAGR 10-Years
-17%
Amgen Inc
NASDAQ:AMGN
Pre-Tax Income
$3.5B
CAGR 3-Years
-18%
CAGR 5-Years
-17%
CAGR 10-Years
-4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Pre-Tax Income
$214.7m
CAGR 3-Years
-55%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Pre-Tax Income
$4.6B
CAGR 3-Years
-14%
CAGR 5-Years
17%
CAGR 10-Years
19%

See Also

What is Intercept Pharmaceuticals Inc's Pre-Tax Income?
Pre-Tax Income
-57.5m USD

Based on the financial report for Sep 30, 2023, Intercept Pharmaceuticals Inc's Pre-Tax Income amounts to -57.5m USD.

What is Intercept Pharmaceuticals Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
4%

Over the last year, the Pre-Tax Income growth was 72%. The average annual Pre-Tax Income growth rates for Intercept Pharmaceuticals Inc have been 44% over the past three years , 30% over the past five years , and 4% over the past ten years .

Back to Top